Press release
Gout Therapeutics Market Size Forecasted To Achieve $5.03 Billion By 2029 With Steady Growth
Gout Therapeutics Market Size
What Is the Gout Therapeutics Market Size and Projected Growth Rate?
In recent times, the market size for gout therapeutics has seen considerable expansion. It's poised to increase from $2.88 billion in 2024 to $3.23 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.2%. Factors contributing to this growth during the historical period include a rise in the occurrence of gout, shifts in lifestyle and diet, high incidences of blood pressure and diabetes, the emergence of xanthine oxidase inhibitors, along with initiatives taken to educate patients.
Expectations are high for a quick expansion in the gout therapeutics market size in the upcoming years. The projected growth for this market is at a compound annual growth rate (CAGR) of 11.7%, reaching $5.03 billion in 2029. Contributing factors to the anticipated growth during the forecast period include increased health care spending, advancement in drug delivery systems, the emergence of new therapies, government-led initiatives for chronic disease management, and support from patient advocacy groups. Major trends going into the forecast period include fresh developments in drug discovery, the approval of innovative drugs, tailored medicine approaches, the rise of telehealth services for managing gout, and ongoing research in therapies that lower urate.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12118
What Are the Major Segments in the Gout Therapeutics Market?
The gout therapeutics market covered in this report is segmented -
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids, Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics, Loop Diuretics
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12118&type=smp
What Are The Driving Gout Therapeutics Market Evolution?
The escalation in gout incidents is foreseen to fuel the advance of the gout therapeutics market. Gout is an inflammatory arthritis condition that triggers pain and inflammation in the joints. The treatment for gout involves alleviating pain, inflammation, and soreness in the joints. Consequently, the swelling occurrence of gout is projected to amplify sales in the gout therapeutics market. For instance, in June 2024, the Australian Institute of Health and Welfare, an American government agency, announced that gout was the underlying cause in 573 fatalities in Australia in 2022, which correlates to 2.2 deaths for every 100,000 individuals. Hence, the escalating prevalence of gout is leading the progression of the gout therapeutics market.
Which Firms Dominate The Gout Therapeutics Market Segments?
Major companies operating in the gout therapeutics market include Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma
What Trends Are Expected to Dominate the Gout Therapeutics Market in the Next 5 Years?
One prominent trend emerging in the gout therapeutics market is product innovation. Many well-established companies in this market are continually designing novel treatments in order to maintain their standings. For instance, US-based pharmaceutical company, Synlogic Inc., introduced a new gout treatment medication named SYNB2081 in August 2022. This drug candidate is a synthetic biotic engineered to reduce uric acid levels and is the second clinical drug developed as a result of the joint research collaboration between Synlogic and Ginkgo, another biotech firm based in the US.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report
Which Is The Largest Region In The Gout Therapeutics Market?
North America was the largest region in the gout therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gout Therapeutics Market?
2. What is the CAGR expected in the Gout Therapeutics Market?
3. What Are the Key Innovations Transforming the Gout Therapeutics Industry?
4. Which Region Is Leading the Gout Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gout Therapeutics Market Size Forecasted To Achieve $5.03 Billion By 2029 With Steady Growth here
News-ID: 3996988 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Vertical Farming Market: Technological Advancemen …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Vertical Farming Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the vertical farming market has seen rapid growth in recent years. Predictions estimate it will increase from $7.74 billion in 2024 to $9.55 billion in 2025. This represents a compound annual growth…
Plant Breeding And CRISPR Plants Market Landscape to 2034: Key Forces Shaping th …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Plant Breeding And CRISPR Plants Market Size By 2025?
In recent years, the market size for plant breeding and CRISPR plants has seen considerable growth. It stands projected to escalate from $13.56 billion in 2024 to a noteworthy $15.5 billion in 2025, boasting a compound…
Soaring Demand Set to Propel Livestock Monitoring Market to $7.14 Billion by 202 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Livestock Monitoring Market Through 2025?
In recent times, there has been a significant increase in the livestock monitoring market size. The market, which stands at $3.48 billion in 2024, is projected to rise to $3.94 billion by 2025, depicting a compound annual…
Emerging Trends to Drive Forestry And Logging Market Growth at 7.9% CAGR Through …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Forestry And Logging Market Size Growth Forecast: What to Expect by 2025?
The market size for forestry and logging has seen a substantial growth in the past couple of years. It is expected to increase from $980.05 billion in 2024 to $1055.36 billion in 2025, with a compound annual…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
